Late filing
Filing comparison
Exousia Bio, Inc. told the SEC it could not file its quarterly report on time
Does not expect a significant change in results. Filed on the statutory due date.
The accountants could not complete the required financial statements, the auditors could not complete their review of the financial statements and periodic report, and management could not complete the Management’s Discussion and Analysis of such financial statements prior to the filing deadline.
Evidence
- Anticipates significant change
- No
- Days past due date
- 0
- Other periodic reports filed
- Yes
- Routine
- Yes
- Severity
- normal
- Source
- Form 12b-25 (notification of late filing)
- Stated reason
- The accountants could not complete the required financial statements, the auditors could not complete their review of the financial statements and periodic report, and management could not complete the Management’s Discussion and Analysis of such financial statements prior to the filing deadline.
- Why
- The company told the SEC it could not file a periodic report on time, using Form 12b-25.